Pharmacists in Otsego, MN Accepting Medicare

8 Pharmacists found. Showing 1 - 8

Dr. Laine Holcomb, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15800 87th St Ne, Otsego, MN 55330 Phone: 763-252-1316

Dr. Zachary Ryan Borgen, PHARMD, MS, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15800 87th St Ne, Otsego, MN 55330 Phone: 763-252-1316    Fax: 763-252-1326

Karl Daniel Voltzke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15800 87th St Ne, Otsego, MN 55330 Phone: 763-252-1316    Fax: 763-252-1326

Bridgette Olutosin Teniola, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15800 87th St Ne, Otsego, MN 55330 Phone: 763-252-1316

Kevin Olson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15800 87th St Ne, T2456, Otsego, MN 55330 Phone: 763-252-1316    Fax: 763-252-1326

Bryan Nguyen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15700 88th St Ne, Otsego, MN 55330 Phone: 763-742-8817

Dave Alan Hewitt, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15800 87th St Ne, T2456, Otsego, MN 55330 Phone: 763-252-1316    Fax: 763-252-1326

Mara Plifka Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15800 87th St Ne, Otsego, MN 55330 Phone: 763-252-1316

News Archive

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

Study examines how masks disrupt facial perception

The identification of people wearing masks has often presented a unique challenge during the pandemic. A new study by researchers from Ben-Gurion University of the Negev (BGU) in Israel and York University in Canada reveals the impact of this predicament and its potentially significant repercussions.

Genetic therapy may help children with Angelman syndrome to overcome seizures

Angelman syndrome is a genetic disease with no cure. Children grow up with severe intellectual disabilities and a range of other problems, arguably the worst of which are epileptic seizures. Now scientists at the UNC School of Medicine have found evidence that genetic therapy may prevent the enhanced seizure susceptibility.

Interface Clinical Research outlines new model for running primary care trials

New clinical trials company, Interface Clinical Research, outlined a new model for running primary care clinical trials at their launch yesterday at the Royal Society in London.

Read more Medical News

› Verified 4 days ago